Completed OBSERVATIONAL NCT06279715

DFI and Aneuploidies

Evaluation of the Association Between the DNA Fragmentation Index (DFI) and the Frequency of Segmental and Total Aneuploidies

Sponsor: Clinique Ovo

Conditions Embryo Disorder

Interventions Preimplantation Genetic Testing for Aneuploidy

Updated 4 times since 2024 Last updated: Jul 29, 2025 Started: Jan 19, 2024 Primary completion: Nov 14, 2024 Completion: Nov 14, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Embryo Disorder, this trial is completed. The trial is conducted by Clinique Ovo and has accumulated 4 data snapshots since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Aug 2025 — Present [monthly]

Completed

Status: Active Not Recruiting → Completed
Sep 2024 — Aug 2025 [monthly]

Active Not Recruiting
Jul 2024 — Sep 2024 [monthly]

Active Not Recruiting
Mar 2024 — Jul 2024 [monthly]

Active Not Recruiting

First recorded

Jan 2024

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Clinique Ovo

Data source: Clinique Ovo

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Montreal, Canada